搜尋
Scinai Immunotherapeutics Ltd
SCNI添加自選
0.238USD
+0.007+3.26%
交易中 （美東）報價延遲15分鐘
824.05K總市值
虧損本益比TTM
關於 Scinai Immunotherapeutics Ltd 公司
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Scinai Immunotherapeutics Ltd簡介
公司代碼SCNI
公司名稱Scinai Immunotherapeutics Ltd
上市日期Jun 07, 2007
CEOReichman (Amir)
員工數量31
證券類型Depository Receipt
年結日Jun 07
公司地址Jerusalem Biopark, 2Nd Floor
城市JERUSALEM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Israel
郵編00000
電話97289302529
網址https://www.scinai.com/
公司代碼SCNI
上市日期Jun 07, 2007
CEOReichman (Amir)
Scinai Immunotherapeutics Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
19.51K
+58.60%
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
Dr. Yael Margolin
Dr. Yael Margolin
External Director
External Director
50.00
--
Mr. Adi Raviv
Mr. Adi Raviv
External Director
External Director
50.00
--
Mr. Samuel J. Moed
Mr. Samuel J. Moed
Director
Director
--
--
Dr. Morris C. Laster, M.D.
Dr. Morris C. Laster, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
19.51K
+58.60%
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
常見問題
Scinai Immunotherapeutics Ltd的前五大股東是誰？
Scinai Immunotherapeutics Ltd的前五大股東如下：Mr. Mark S. Germain
有多少機構持有Scinai Immunotherapeutics Ltd(SCNI)的股份？
截至2026Q1，共有23家機構持有Scinai Immunotherapeutics Ltd的股份，合計持有的股份價值約為179.71K，占公司總股份的5.08% 。與2025Q4相比，機構持股有所增加，增幅為33890.00。